Ascendis Pharma submits TransCon CNP NDA to FDA
Ascendis Pharma (ASND) announced that it has submitted its new drug application to the FDA for TransCon CNP for the treatment of children with ...
Vanda Pharmaceuticals submits NDA to FDA for Bysanti
Vanda Pharmaceuticals (VNDA) announced that a New Drug Application was submitted to the U.S. FDA requesting marketing approval of Bysanti for ...